These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6139566)

  • 1. Nalidixic acid for shigellosis.
    Parry HE
    Lancet; 1983 Nov; 2(8360):1206. PubMed ID: 6139566
    [No Abstract]   [Full Text] [Related]  

  • 2. Bacillary dysentery. An institutional outbreak of Shigella sonnei: treatment of 36 cases with nalidixic acid.
    Fernandez LA
    J Kans Med Soc; 1966 Jul; 67(7):359-60 passim. PubMed ID: 5330682
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic effectiveness of nevigramon in the complex treatment of acute dysentery].
    Gebesh VV; Koval'chuk VK; Ianushevskaia RI; Sofienko NIa; Lysak LI
    Vrach Delo; 1980 May; (5):110-3. PubMed ID: 6994350
    [No Abstract]   [Full Text] [Related]  

  • 4. Increasing incidence of resistance to nalidixic acid in shigellas from humans in England and Wales: implications for therapy.
    Cheasty T; Day M; Threlfall EJ
    Clin Microbiol Infect; 2004 Nov; 10(11):1033-5. PubMed ID: 15522014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shigella isolation in Vellore, south India (1997-2001).
    Jesudason MV
    Indian J Med Res; 2002 Jan; 115():11-3. PubMed ID: 12424931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical study of wintomylon in the treatment of shigellosis.
    Yu PC; Chen HS
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1965; 6(3):127-31. PubMed ID: 5861506
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of bacillary dysentery in Vietnamese children: two doses of ofloxacin versus 5-days nalidixic acid.
    Vinh H; Wain J; Chinh MT; Tam CT; Trang PT; Nga D; Echeverria P; Diep TS; White NJ; Parry CM
    Trans R Soc Trop Med Hyg; 2000; 94(3):323-6. PubMed ID: 10975012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotics in the management of shigellosis.
    Wkly Epidemiol Rec; 2004 Sep; 79(39):355-6. PubMed ID: 15571173
    [No Abstract]   [Full Text] [Related]  

  • 9. Nalidixic acid for shigellosis.
    McCormack JG
    Lancet; 1983 Nov; 2(8358):1091. PubMed ID: 6138641
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative efficacy of nalidixic acid and ampicillin for severe shigellosis.
    Haltalin KC; Nelson JD; Kusmiesz HT
    Arch Dis Child; 1973 Apr; 48(4):305-12. PubMed ID: 4574641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized clinical trial of norfloxacin for shigellosis.
    Bhattacharya SK; Bhattacharya MK; Dutta P; Sen D; Rasaily R; Moitra A; Pal SC
    Am J Trop Med Hyg; 1991 Dec; 45(6):683-7. PubMed ID: 1763794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nalidixic acid in resistant shigella infection.
    Agrawal ML; Mukherjee SP; Prasad SS
    J Assoc Physicians India; 1987 May; 35(5):390. PubMed ID: 3693298
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of bacillary dysentery: a comparison between enoxacin and nalidixic acid.
    De Mol P; Mets T; Lagasse R; Vandepitte J; Mutwewingabo A; Butzler JP
    J Antimicrob Chemother; 1987 May; 19(5):695-8. PubMed ID: 3301783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sonne dysentery. Some observations on a food-poisoning incident during an epidemic and on the development of resistance to nalidixic acid.
    Steede FD; Wormald PJ
    Public Health; 1969 May; 83(4):191-5. PubMed ID: 4895079
    [No Abstract]   [Full Text] [Related]  

  • 15. Controlled comparison of nalidixic acid or lactulose with placebo in shigellosis.
    Hansson HB; Barkenius G; Cronberg S; Juhlin I
    Scand J Infect Dis; 1981; 13(3):191-3. PubMed ID: 7031858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy for shigellosis. I. Randomized, double-blind trial of nalidixic acid in childhood shigellosis.
    Salam MA; Bennish ML
    J Pediatr; 1988 Nov; 113(5):901-7. PubMed ID: 3054035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults.
    Rogerie F; Ott D; Vandepitte J; Verbist L; Lemmens P; Habiyaremye I
    Antimicrob Agents Chemother; 1986 May; 29(5):883-6. PubMed ID: 3524434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of norfloxacin for shigellosis: a double-blind randomised clinical trial.
    Bhattacharya MK; Nair GB; Sen D; Paul M; Debnath A; Nag A; Dutta D; Dutta P; Pal SC; Bhattacharya SK
    J Diarrhoeal Dis Res; 1992 Sep; 10(3):146-50. PubMed ID: 1430968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of nalidixic acid resistance in Shigella sonnei isolated from patients having acute diarrheal disease: report from eastern province of Saudi Arabia.
    Panhotra BR; Saxena AK; Al-Mulhim K
    Jpn J Infect Dis; 2004 Jun; 57(3):116-8. PubMed ID: 15218222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International note. Antibiotics in the management of shigellosis.
    Can Commun Dis Rep; 2004 Dec; 30(23):202-3. PubMed ID: 15603533
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.